
|Articles|December 4, 2014
Biorasi Acquires European CRO, Advanced Biosciences Research
Biorasi LLC announced that it has completed the acquisition of Advanced Biosciences Research
Advertisement
Biorasi LLC, a global CRO, announced that it has completed the acquisition of Advanced Biosciences Research (ABR), a European CRO with operations in United Kingdom, Germany, Switzerland, and Sweden. ABR is a highly integrated group that has provided Phase II to IV clinical research project management, monitoring, and regulatory outsourcing for its sponsors in the region.
Read the full release
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Clinical Trials in 2026: Platformization, AI Fluency, and the Redrawing of the Value Chain
2
FDA Issues Draft Guidance to Advance Bayesian Methods in Clinical Trials
3
Extending Trial Registries for an AI-Driven Era of Patient Discovery
4
ACT Brief: Moving Beyond AI Pilots, FDA Advances Bayesian Trials, and Sites Strained by Trial Design
5




